RedHawk Holdings Corp. - FORM 10-K

Attached files

file	filename
EX-32.2 - RedHawk Holdings Corp.	ex32-2.htm
EX-32.1 - RedHawk Holdings Corp.	ex32-1.htm
EX-31.2 - RedHawk Holdings Corp.	ex31-2.htm
EX-31.1 - RedHawk Holdings Corp.	ex31-1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

x	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the Fiscal Year Ended January 31, 2014

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT

	For the transition period from ______________ to ____________

Commission file number 000-54323

INDEPENDENCE ENERGY, CORP.

(Exact name of registrant as specified in its charter)

Nevada		20-3866475
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

3020 Old Ranch Parkway, Suite 300, Seal Beach, CA		90740
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (562) 799-5588

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Name of Each Exchange On Which Registered
N/A		N/A

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.001 par value

(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer o	Accelerated Filer o

Non-Accelerated Filer o	Smaller Reporting Company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The aggregate market value of Common Stock held by non-affiliates of the Registrant on July 31, 2013 was $729,335 based on a $0.0085 average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter.

Indicate the number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date.

345,188,164 common shares as of April 29, 2014.

DOCUMENTS INCORPORATED BY REFERENCE

None.

Table of Contents

Item 1.	Business	3
Item 1A.	Risk Factors	11
Item 1B.	Unresolved Staff Comments	14
Item 2.	Properties	14
Item 3.	Legal Proceedings	17
Item 4.	Mine Safety Disclosures	17
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	17
Item 6.	Selected Financial Data	18
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	18
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 8.	Financial Statements and Supplementary Data	23
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	36
Item 9A.	Controls and Procedures	36
Item 9B.	Other Information	37
Item 10.	Directors and Executive Officers	38
Item 11.	Executive Compensation	41
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	43
Item 13.	Certain Relationships and Related Transactions, and Director Independence	45
Item 14.	Principal Accounting Fees and Services	45
Item 15.	Exhibits	46

PART I

Item 1. Business

This annual report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled “Risk Factors”, that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles.

In this annual report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common shares” refer to the common shares in our capital stock.

As used in this annual report, the terms “we”, “us”, “our” and “our company” mean Independence Energy Corp., unless otherwise indicated.

Corporate Overview

We were incorporated in the State of Nevada on November 30, 2005 under the name “Oliver Creek Resources Inc.”. At inception, we were an exploration stage company engaged in the acquisition, exploration and development of natural resource properties.

Effective August 12, 2008, we effected a forward stock split of our issued and outstanding common stock on a 12 new for 1old basis such that, our authorized capital remains at 75,000,000 shares of common stock with a par value of $0.001 and our issued and outstanding shares increased from 2,000,000 shares of common stock to 24,000,000 shares of common stock. Also effective August 12, 2008, we have changed our name from “Oliver Creek Resources Inc.” to “Independence Energy Corp.”. The change of name was approved by our directors and a majority of our shareholders.

The name change, forward stock split and reduction of authorized capital became effective with the Over-the-Counter Bulletin Board at the opening for trading on August 12, 2008 under the new stock symbol “IDNG”.

Effective June 22, 2012, we effected a forward split of our authorized and issued and outstanding shares of common stock on a 5 new for 1 old basis such that, our authorized capital increased from 75,000,000 to 375,000,000 shares of common stock and correspondingly, our issued and outstanding shares of common stock increased from 24,360,831 to 121,804,155 shares of common stock, all with a par value of $0.001. Our CUSIP number is 45343Y 205.

Current Business

We are classified as a crude petroleum and natural gas company and, until recently, our business focused exclusively on oil and natural gas exploration and production in the United States. We continue to hold a 10% working interests in the Quinlan Wells, described below. We do not directly hold the leases underlying the wells and therefore are not responsible for the payment or evaluation of any obligations under the leases. The leaseholder of the property is responsible for paying and maintaining the leases. As a working interest holder, we are responsible for our pro-rata share of lease operating expenses. We may sell our working interest in the Quinlan Wells if we identify a favorable opportunity or otherwise determine that disposing of the asset would be in the best interest of the Company. As at the date of this report we have been invoiced for approximately $58,300 in lease operating expenses related to the Quinlan wells. This amount remains unpaid. Our failure to pay the outstanding amounts entitles the lease holder to foreclose on our working interest. We are actively seeking purchasers to assume our working interest and related liabilities.

Business History

On December 15, 2011, we closed the acquisition of a 2.5% working interest in the Quinlan Lease from Wise Oil and Gas LLC, with the option to increase that interest to 10%. On the closing of the acquisition on December 15, 2011, we began generating revenue from the operating well on the property even though the well is in the exploration and evaluation stage. On December 23, 2011, we closed an acquisition for an additional 2.5% working interest for a total of 5% working interest. The Quinlan Lease is located in Pottawatomie County, Oklahoma.

Effective March 1, 2012, our company, paid an additional $78,080 to Wise Oil and Gas for an additional 5% participation in the Quinlan 1, 2 and 3 wells located in Pottawatomie County, Oklahoma at a cost of $15,616 per 1%. Our company now holds a 10% interest in the Quinlan 1, 2 and 3 wells. As at the date of this report we have been invoiced for approximately $58,300 in lease operating expenses related to the Quinlan wells. This amount remains unpaid. Our failure to pay the outstanding amounts entitles the lease holder to foreclose on our working interest. We are actively seeking purchasers to assume our working interest and related liabilities.

Effective March 29, 2012, our company, acquired a 5% working interest, on a 70% net revenue interest, in a drilling program in Coleman County, Texas. The interest was acquired from MontCrest Energy, Inc. for total consideration of $115,000. On June 18, 2012, we amended and replaced the original agreement to acquire a 7% working interest, on a 75% net revenue interest in two well drilling programs, for additional consideration of $46,000.

On May 29, 2012, we entered into and closed a purchaser agreement and bill of sale to acquire a 2.5% working interest (on a 70% net revenue interest) in two oil and gas wells: the Taylor - MEI # 113 and Taylor - MEI # 115 from MontCrest. The wells are located on MontCrest's Taylor Lease in Coleman County, Texas. The 2.5% interest was acquired for total consideration of $82,500. The interest includes approximately 20 acres of land surrounding each well above the measured depth of four thousand feet. The wells are located within T. & N.O.R.R Survey No. 28, Abstract 1667 in Coleman County, Texas.

On June 8, 2012, we entered into and closed a joint development and operating agreement with MontCrest Energy Properties, Inc., MontCrest Energy, Inc. and Black Strata, LLC, to acquire a 12.5% working interest, with an option to acquire an additional 12.5% working interest in the areas in mutual interests from MontCrest Energy, Inc. The 12.5% interest was acquired for total consideration of $90,784.50. The areas in mutual interest, consists of approximately 2,421 acres, in Coleman County, Texas, located within T. & N.O.R.R Survey Block, Abstract 1640, Abstract 654, Abstract 851 and Abstract 865.

On February 28, 2013, we entered into a compromise, settlement and property exchange agreement dated February 25, 2013 with MontCrest Energy, Inc. and Black Strata, LLC. Pursuant to the terms of the agreement, we transferred to MontCrest our 25% working interests in Wells 105, 106, 113 and 115 of the Coleman County South Leases located in Coleman County, Texas, in consideration of a 100% interest in approximately 1,400 acres of the Coleman County South Lease held by Black Strata, LLC. As at April 1, 2014, all oil & gas leases located on the Coleman County South Property were expired. Our management decided not to renew the Coleman Country South leases in light of our recent Asset Purchase Agreement with American Medical Distributors, LLC (described below) and its decision to focus our operations on the development of a medical device distribution business. We have no outstanding obligations in relation to the leases or the Compromise, Settlement, and Property Exchange Agreement dated February 25, 2013.

On April 5, 2013, we entered into a private placement subscription agreement with Europa Capital AG pursuant to which we issued to Europa a convertible debenture in the aggregate amount of $46,000. The convertible debenture carried interest at the rate of 6% per annum and could be converted into shares of our common stock at the rate of $0.01 per share Interest and principal were payable on the 3 year anniversary of the debenture, provided that any unconverted portions may be pre-paid at our discretion. As at January 31, 2014, we owed $2,284 of accrued interest in respect of the debenture. On January 31, 2014, the debenture holder forgave the convertible promissory note and all accrued interest, resulting in a gain on forgiveness of loan of $48,284.

Effective July 22, 2013, we entered into and closed a securities purchase agreement with Asher Enterprises, Inc. (“Asher”). Under the terms of the agreement, our company issued an 8% convertible promissory note, in the principal amount of $57,000, which matured on April 17, 2014 and could be converted into shares of our company's common stock at a rate of 58% of the market price on any conversion date, any time after 180 days from July 15, 2013, subject to adjustments as further set out in the note. Our company had the right to prepay the note together with all accrued interest within 180 days of July 15, 2013 subject to a prepayment penalty equal to 15% during the first 30 days of the prepayment period and increasing by 5% during each subsequent 30 day period. Following the maturity date of April 17, 2014, the note shall bore interest at the rate of 22%. Subsequent to January 31, 2014, all remaining principal and accrued interest in respect of the convertible promissory note was converted into shares of our common stock.

On September 23, 2013, we closed a securities purchase agreement dated September 17, 2013 with Asher. Under the terms of the agreement, our company issued an 8% convertible promissory note, in the principal amount of $32,500, which matured on June 19, 2014 and could be converted into shares of our company’s common stock at a rate of 58% of the market price on any conversion date, any time after 180 days from June 19, 2014, subject to adjustments as further set out in the note. Our company had the right to prepay the note together with all accrued interest within 180 days of September 17, 2013 subject to a prepayment penalty equal to 15% during the first 30 days of the prepayment period and increasing by 5% during each subsequent 30 day period. Following the maturity date of June 19, 2014, the note bore interest at the rate of 22%. Subsequent to January 31, 2014, all remaining principal and accrued interest in respect of the convertible promissory note was converted into shares of our common stock.

Medical Device Business

On March 31, 2014, we entered into and closed an asset purchase agreement with American Medical Distributors, LLC (“AMD”). Pursuant to the agreement we have acquired from AMD all right, title and interest of AMD in and to a certain distribution contract (the “HuBDIC Agreement”) dated November 27, 2013 with HuBDIC Co. Ltd., a Korea corporation, pursuant to which AMD has been granted the exclusive right to distribute in the Americas certain professional and consumer grade non-contact thermometers known as the Thermofinder FS-700 Pro and FS-700 (retail version), and any future versions. As additional consideration, we have also received $60,000 and any assets of AMD related to its distribution business, including, all sales leads and related materials (collectively, including the HuBDIC Agreement, the “AMD Assets”).

The material terms of the HuBDIC Agreement are as follows: (a) term of 5 years from November 7, 2013; (b) subject to FDA marketing clearance of the HuBDIC products, which is anticipated, we are required to purchase a minimum of 3,000 product units for re-sale during year 1 of the distribution period, 8,000 during year 2, and 15,000 during each subsequent year; (c) a $10,000 distribution fee paid to HuBDIC by AMD will be credited toward the first product order; and (d) the deposit is refundable to us at our election, and we may terminate the HuBDIC Agreement in the event FDA premarket clearance is not granted by April 26, 2014An application for premarket clearance was submitted by HuBDIC on January 20, 2014, however premarket clearance has not be obtained as at the date of this report. We have not elected to terminate the agreement and continue to anticipate receipt of premarket clearance.

In consideration of the AMD Assets, we have agreed to issue to four designees of AMD an aggregate of 152,172,287 shares of our common stock.

About Thermofinder FS-700 and FS-700 Pro

The Thermofinder is medical grade non-contact thermometer that is currently approved and distributed in Asia and Europe. It is available in two version, the FS-700 (retail model) and FS-700 Pro (professional model). The device`s features include the following:

·	Two measuring modes including body temperature and surface/ambience modes which allows the reading of air temperature and fluid temperature (bath water, baby’s bottles);

·	Non-invasive design—Operated by pointing and pressing within 3-5 centimeters of the patient’s forehead or other target;

·	Easy to read LCD backlit display with multi-color screen and alert function. A green light is shown for normal reading, and an orange light for high readings.

·	Less than 2 second reading response time.

·	Reading accuracy within 0.3 degrees celcius for body temperature and 2 degrees celcius for object temperature.

·	International Organization for Standardization (ISO) 13485 and American Society for Testing and Materials (ASTM) Compliant.

·	More hygienic than conventional oral and ear reading thermometers—Eliminating the need for probe covers and reducing sterilization requirements.

·	The PRO model is equipped with a medical grade protection cover, logo lanyard, anti-microbial option, and rechargeable battery and station.

HuBDIC Co. Ltd. submitted an application to the FDA on January 29, 2014 seeking premarket clearance for the Thermofinder. Premarket clearance is required before any marketing, sales or distribution of the product may be conducted in the U.S. Our management believes that clearance for the Thermofinder is forthcoming based on HuBDIC`s past successful clearance of thermometers which, in the opinion of our management, are substantially equivalent to the Thermofinder as a predicate device. Notwithstanding our management`s assessment, there is no guarantee that premarket clearance will be obtained in a timely manner, if at all.

Markets and Marketing Plan

The Thermofinder is intended to provide economic thermometry to a broad base of users and is ideal for home and institutional use. The market for the device includes:

·	Retail Pharmacies

Hospitals

·	Physicians Offices

·	Private and Public Healthcare Clinics

·	Corrections Facilities

Schools

·	Veterinary Clinics

·	Emergency Services

·	Long Term Care Facilities

Subject to receipt of FDA premarket clearance, we intend to focus our initial marketing on the professional market. This strategy will reduce initial marketing costs, while establishing product awareness in the health community.

Plan of Operation

Our plan of operations for the next 12 months is to prepare our marketing and distribution strategy and our sales and distribution force in anticipation of FDA marketing clearance for the Thermofinder. Although our management believes that FDA marketing clearance of the Thermofinder is forthcoming, there is no guarantee that approval will be obtained or that it will be obtained in a timely manner. We will also require additional capital to carry out our current business plan. We currently do not have sufficient financing to fully execute our business plan and there is no assurance that we will be able to obtain the necessary financing to do so.

We may not be able to fund our cash requirements through our current operations. Historically, we have been able to raise a limited amount of capital through private placements of our equity stock, but we are uncertain about our continued ability to raise funds privately. Further, we believe that our company may have difficulties raising capital until FDA approval is granted. If we are unable to secure adequate capital to continue our acquisition efforts, our shareholders may lose some or all of their investment and our business may fail.

We estimate that our expenses over the next 12 months (beginning February 2014) will be approximately $1,000,000 as described in the table below. These estimates may change significantly depending on the performance of our products in the marketplace and our ability to raise capital from shareholders or other sources.

Description	Estimated Completion Date	Estimated Expenses ($)

Legal and accounting fees	12 months		100,000
Marketing and advertising	12 months		500,000
Employees and Consultant Compensation	12 months		250,000
General and Administrative	12 months		150,000
Total			1,000,000

We intend to meet our cash requirements for the next 12 months through a combination of debt financing and equity financing by way of private placements and, subject to timely receipt of FDA marketing clearance, through product sales. We currently do not have any arrangements in place to complete any private placement financings and there is no assurance that we will be successful in completing any private placement financings on terms that will be acceptable to us. We may not raise sufficient funds to fully carry out our business plan, in which case we intend to scale back our expenditures in order to accommodate the budget available to us.

Insurance

We do not maintain any insurance but will be required to maintain insurance in the future prior to launching our medical device distribution operations. Because we do not currently have any insurance, if we are made a party to a liability action, we may not have sufficient funds to defend the litigation. If that occurs a judgment could be rendered against us that could cause us to cease operations.

Competition

The medical device distribution industry is highly competitive. We are a development stage company without established operations in our industry and have a weak competitive position. We aim to compete with junior and senior medical device manufacturers or distributors who are actively seeking to develop or acquire and sell devices competitive with our own. Competition for the medical device assets is intense and we may lack the technological information, human resources, infrastructure, expertise, and financial resources available to our competitors.

Many of the companies with which we aim to compete for financing and for the acquisition of medical device assets have greater financial and technical resources than those available to us. Accordingly, these competitors may be able to spend greater amounts on assets of merit or on developing and distributing their own technologies. Such competition could adversely impact our ability to attain the financing necessary for us to develop our current assets or obtain and develop future assets.

General competitive conditions may be substantially affected by various forms of regulation introduced from time to time by the governments of the United States and other countries, as well as factors beyond our control, including overall levels of supply and demand for the product types which we seek to distribute.

In the face of competition, we may not be successful in acquiring or successfully exploiting any distribution rights which we have acquired or may acquire in the future. Despite this, we hope to compete successfully in the medical device industry by:

·	keeping our costs low;

·	relying on the strength of our management’s and future sales team’s contacts;

·	utilizing our team's previous product and sales and support experience in the specific device area; and

·	using our size and experience to our advantage by adapting quickly to changing market conditions or responding swiftly to potential opportunities.

Research and Development Expenditures

We have not incurred any research expenditures over the past two fiscal years.

Intellectual Property

We do not own, either legally or beneficially, any patent or trademark. We have established a website and maintain the domain www.independenceenergycorp.com. We have also purchased the domain independencehealthcorp.com.

Employees; Identification of Certain Significant Employees

Currently, we do not have any employees. Additionally, we have not entered into any consulting or employment agreements with our president, chief executive officer, chief financial officer, treasurer and secretary other than previously filed. Our directors, executive officers and certain contracted individuals play an important role in the running of our company. We do not expect any material changes in the number of employees over the next 12 month period. We do and will continue to outsource contract employment as needed. In that regard we intend to engage contractors from time to time to consult with us on specific corporate affairs or to perform specific tasks in connection with our anticipated sales and marketing programs.

Government Regulation

Regulation of Medical Device Distribution Operations

Government authorities in the United States, Canada, and other countries in the Americas regulate the research, development, testing, manufacturing, labeling, promotion, advertising, distribution, marketing and export and import of medical devices at the federal, state and local levels. The process of obtaining regulatory approvals and the subsequent substantial compliance with appropriate federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources.

In the United States, thermometers for human clinical use are classified as medical devices and require (i) an establishment license and (ii) depending on the class of device sought to be marketed, premarket approval (PMA) or the less rigorous premarket clearance.

Establishment License

Owners or operators of places of business (also called establishments or facilities) that are involved in the production and distribution of medical devices intended for use in the United States (U.S.) are required to register annually with the FDA. This process is known as establishment registration. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. As domestic distributors of medical devices in the United States, we will not be required to obtain an establishment license, although owner/operators of the products we distribute will be so required. Certain countries do not require establishment license.

Depending on the class designation of the device sought to be marketed, the owner/operator of the product must also obtain premarket approval (PMA) or premarket notification clearance before marketing in the U.S.

U.S. Medical Device Class Designations:

Class I includes products of which several examples are already approved and marketed in Canada or USA. As long as the basic science remains the same, the application for approval of a new product is straight forward. One product in this category would be a pregnancy test or regular needle/syringes.

Class II products are those which do not need to be injected (the device itself) or inserted into the patient (non-invasive). Often these products are approved and sold throughout the world. The products which we are currently focusing on distributing all belong to Class II. In order to secure the necessary license for these products, we are required to submit all the documentation which lead to the approval of the products in other countries. In our case, our products are already approved in Europe and Korea. As far as for FDA compliance is concerned, we are required to submit to the all the scientific data, results, approval process and certificates of good quality management, ISO 13485. Usually, products which have the ISO accreditation will satisfy FDA requirements.

Class III and IV include medical device which use invasive techniques. If the medical device has been approved in another region, it is considered Class III. If it is brand new, it is considered Class IV. Invasive tests such as colonoscopy, endoscopy, body lesion removal etc., are all considered Class III or IV. None of our products fall within Class III or IV.

Premarket Clearance

We intend to focus our medical device distribution business on Class I or II devices. Electronic Clinical Thermometers such as the Thermofinder are classified as Class II devices by the FDA are not subject to Premarket Approval (PMA).

Each person who wants to market in the U.S., a Class I, II, and III device intended for human use, for which a Premarket Approval (PMA) is not required, must submit a 510(k) to FDA unless the device is exempt from 510(k) requirements of the Federal Food, Drug, and Cosmetic Act (the Act) and does not exceed the limitations of exemptions in .9 of the device classification regulation chapters (e.g., 21 CFR 862.9, 21 CFR 864.9). There is no 510(k) form, however, 21 CFR 807 Subpart E describes requirements for a 510(k) submission. Before marketing a device, each submitter must receive an order, in the form of a letter, from FDA which finds the device to be substantially equivalent (“SE”) and states that the device can be marketed in the U.S. This order "clears" the device for commercial distribution.

A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, substantially equivalent, to a legally marketed device (21 CFR 807.92(a)(3)) that is not subject to PMA. Submitters must compare their device to one or more similar legally marketed devices and make and support their substantial equivalency claims. A legally marketed device, as described in 21 CFR 807.92(a)(3), is a device that was legally marketed prior to May 28, 1976, for which a PMA is not required, or a device which has been reclassified from Class III to Class II or I, or a device which

has been found SE through the 510(k) process. The legally marketed device(s) to which equivalence is drawn is commonly known as the "predicate." Although devices recently cleared under 510(k) are often selected as the predicate to which equivalence is claimed, any legally marketed device may be used as a predicate. Legally marketed also means that the predicate cannot be one that is in violation of the Act.

Until the submitter receives an order declaring a device SE, the submitter may not proceed to market the device. Once the device is determined to be SE, it can then be marketed in the U.S. The SE determination is usually made within 90 days and is made based on the information submitted by the submitter.

Substantial Equivalence

A 510(k) requires demonstration of substantial equivalence to another legally U.S. marketed device. Substantial equivalence means that the new device is at least as safe and effective as the predicate.

A device is substantially equivalent if, in comparison to a predicate it:

·	has the same intended use as the predicate; and

·	has the same technological characteristics as the predicate;

·	has the same intended use as the predicate; and

·	has different technological characteristics and the information submitted to FDA;

·	does not raise new questions of safety and effectiveness; and

·	demonstrates that the device is at least as safe and effective as the legally marketed device.

A claim of substantial equivalence does not mean the new and predicate devices must be identical. Substantial equivalence is established with respect to intended use, design, energy used or delivered, materials, chemical composition, manufacturing process, performance, safety, effectiveness, labeling, biocompatibility, standards, and other characteristics, as applicable.

A device may not be marketed in the U.S. until the submitter receives a letter declaring the device substantially equivalent. If FDA determines that a device is not substantially equivalent, the applicant may:

·	resubmit another 510(k) with new data,

·	request a Class I or II designation through the de novo process

·	file a reclassification petition, or

·	submit a premarket approval application (PMA).

Status of Thermofinder Premarket Clearance

HuBDIC Co. Ltd. has made a 510(k) submission to the FDA on January 29, 2014 to obtain premarket clearance for the Thermofinder FS-700 and FS-700 Pro. Our management believes that premarket clearance for the Thermofinder is forthcoming based on HuBDIC`s past successful clearance of thermometers which, in the opinion of our management, are substantially equivalent to the Thermofinder. Notwithstanding our management`s assessment, there is no guarantee that premarketing approval will be obtained in a timely manner, if at all.

REPORTS TO SECURITY HOLDERS

We are required to file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission and our filings are available to the public over the internet at the Securities and Exchange Commission’s website at http://www.sec.gov. The public may read and copy any materials filed by us with the Securities and Exchange Commission at the Securities and Exchange Commission’s Public Reference Room at 100 F Street N.E. Washington D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the Securities and Exchange Commission at 1-800-732-0330. The SEC also maintains an Internet site that contains reports, proxy and formation statements, and other information regarding issuers that file electronically with the SEC, at http://www.sec.gov.

Item 1A. Risk Factors

Risks Related to Our Overall Business Operations

We have a limited operating history with significant losses and expect losses to continue for the foreseeable future.

We have yet to establish any history of profitable operations. We have incurred net losses of $543,622 and $111,124 for the fiscal years ended January 31, 2014 and 2013, respectively. As a result, at January 31, 2014, we had an accumulated deficit of $813,192. We have not generated any revenues since our inception and do not anticipate that we will generate revenues sufficient to sustain our operations for the foreseeable future. Our profitability will require the successful commercialization of our medical device technology or future products for which we may acquire a distribution license. We may not be able to successfully exploit any distribution rights which we acquire and may never become profitable.

There is doubt about our ability to continue as a going concern due to recurring losses from operations, accumulated deficit and insufficient cash resources to meet our business objectives, all of which means that we may not be able to continue operations.

Our independent auditors have added an explanatory paragraph to their audit opinion issued in connection with the financial statements for the years ended January 31, 2014 and 2013, respectively, with respect to their doubt about our ability to continue as a going concern. As discussed in Note 1 to our financial statements for the year ended January 31, 2014, we have generated operating losses since inception, and our cash resources are insufficient to meet our planned business objectives. We expect to continue to incur development costs and operating costs, losses and negative cash flows until our products gain market acceptance sufficient to generate a commercially viable and sustainable level of sales, and/or additional products are developed and commercially released and sales of such products made so that we are operating in a profitable manner. Our history of losses and no revenues raise substantial doubt about our ability to continue as a going concern.

We have had negative cash flows from operations since inception. We will require significant additional financing, the availability of which cannot be assured, and if our company is unable to obtain such financing, our business may fail.

To date, we have had negative cash flows from operations and have depended on sales of our equity securities and debt financing to meet our cash requirements. We may continue to have negative cash flows. We have estimated that we will require approximately $1,000,000 to carry out our business plan for the next twelve months. There is no assurance that actual cash requirements will not exceed our estimates. We will require additional financing to finance working capital and pay for operating expenses and capital requirements until we achieve a positive cash flow.

Our ability to market and sell our medical devices will be dependent upon our ability to raise significant additional financing. If we are unable to obtain such financing, we will not be able to fully develop our business. Specifically, we will need to raise additional funds to:

·	support our planned growth and carry out our business plan;

·	hire top quality personnel for all areas of our business; and

·	address competing technological and market developments.

We may not be able to obtain additional equity or debt financing on acceptable terms as required. Even if financing is available, it may not be available on terms that are favorable to us or in sufficient amounts to satisfy our requirements. Any additional equity financing may involve substantial dilution to our then existing shareholders. If we require, but are unable to obtain, additional financing in the future, we may be unable to implement our business plan and our growth strategies, respond to changing business or economic conditions, withstand adverse operating results and compete effectively. More importantly, if we are unable to raise further financing when required, we may be forced to scale down our operations and our ability to generate revenues may be negatively affected.

If we fail to effectively manage the growth of our company and the commercialization of our medical devices, our future business results could be harmed and our managerial and operational resources may be strained.

As we proceed with the commercialization of our medical devices and the expansion of our marketing and commercialization efforts, we expect to experience significant growth in the scope and complexity of our business. We will need to add staff to market our services, manage operations, handle sales and marketing efforts and perform finance and accounting functions. We anticipate that we will be required to hire a broad range of additional personnel in order to successfully advance our operations. This growth is likely to place a strain on our management and operational resources. The failure to develop and implement effective systems, or to hire and retain sufficient personnel for the performance of all of the functions necessary to effectively service and manage our potential business, or the failure to manage growth effectively, could have a material adverse effect on our business and financial condition.

If premarket clearance for our sole medical device asset is not obtained in a timely manner our business may fail.

We are unable to market and sell the Thermofinder FS-700 and FS-700 PRO until premarket clearance is granted by the FDA. HuBDIC Co. Ltd., the owner of the Thermofinder technology, has made a 510(k) submission to the FDA to seek premarket clearance for the Thermofinder. Although our management believes that premarket clearance for the Thermofinder is forthcoming based on HuBDIC`s past successful clearance of similar thermometers, there is no guarantee that premarketing clearance will be obtained in a timely manner, if at all. If premarket clearance is not obtained in a timely manner, we may not have sufficient opportunity to take advantage of our acquired distribution rights, which expire on November 7, 2018. Furthermore, there is no guarantee that we will successful in renewing our license or acquiring distribution rights for any other products. Accordingly, if premarket clearance is not obtained in a timely manner our ability to generate sales and revenues, to solicit financing, and to otherwise sustain our business will be materially impaired, which may cause our business to fail.

Risks Related to the Market for Our Stock

The market price of our common stock can become volatile, leading to the possibility of its value being depressed at a time when you may want to sell your holdings.

The market price of our common stock can become volatile. Numerous factors, many of which are beyond our control, may cause the market price of our common stock to fluctuate significantly. These factors include: our earnings releases, actual or anticipated changes in our earnings, fluctuations in our operating results or our failure to meet the expectations of financial market analysts and investors; changes in financial estimates by us or by any securities analysts who might cover our stock; speculation about our business in the press or the investment community; significant developments relating to our relationships with our customers or suppliers; stock market price and volume fluctuations of other publicly traded companies and, in particular, those that are in our industry; customer demand for our products; investor perceptions of our industry in general and our Company in particular; the operating and stock performance of comparable

companies; general economic conditions and trends; announcements by us or our competitors of new products, significant acquisitions, strategic partnerships or divestitures; changes in accounting standards, policies, guidance, interpretation or principles; loss of external funding sources; sales of our common stock, including sales by our directors, officers or significant stockholders; and additions or departures of key personnel. Securities class action litigation is often instituted against companies following periods of volatility in their stock price. Should this type of litigation be instituted against us, it could result in substantial costs to us and divert our management’s attention and resources.

Moreover, securities markets may from time to time experience significant price and volume fluctuations for reasons unrelated to the operating performance of particular companies. These market fluctuations may adversely affect the price of our common stock and other interests in our Company at a time when you want to sell your interest in us. We do not intend to pay dividends on shares of our common stock for the foreseeable future.

We have never declared or paid any cash dividends on shares of our common stock.

We intend to retain any future earnings to fund the operation and expansion of our business and, therefore, we do not anticipate paying cash dividends on shares of our common stock in the foreseeable future.

We are subject to penny stock regulations and restrictions and you may have difficulty selling shares of our common stock.

The SEC has adopted regulations which generally define so-called “penny stocks” to be an equity security that has a market price less than $5.00 per share or an exercise price of less than $5.00 per share, subject to certain exemptions. Our common stock is therefore subject to Rule 15g-9 under the Exchange Act, or the Penny Stock Rule. This rule imposes additional sales practice requirements on broker-dealers that sell such securities to persons other than established customers and “accredited investors” (generally, individuals with a net worth in excess of $1,000,000 or annual incomes exceeding $200,000, or $300,000 together with their spouses). For transactions covered by the Penny Stock Rule, a broker-dealer must make a special suitability determination for the purchaser and have received the purchaser’s written consent to the transaction prior to sale. As a result, this rule may affect the ability of broker-dealers to sell our securities and may affect the ability of purchasers to sell any of our securities in the secondary market.

For any transaction involving a penny stock, unless exempt, the rules require delivery, prior to any transaction in a penny stock, of a disclosure schedule prepared by the SEC relating to the penny stock market. Disclosure is also required to be made about sales commissions payable to both the broker-dealer and the registered representative and current quotations for the securities. Finally, monthly statements are required to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stock.

There can be no assurance that our common stock will qualify for exemption from the Penny Stock Rule. In any event, even if our common stock were exempt from the Penny Stock Rule, we would remain subject to Section 15(b)(6) of the Exchange Act, which gives the SEC the authority to restrict any person from participating in a distribution of penny stock, if the SEC finds that such a restriction would be in the public interest.

We are not likely to pay cash dividends in the foreseeable future.

We intend to retain any future earnings for use in the operation and expansion of our business. We do not expect to pay any cash dividends in the foreseeable future but will review this policy as circumstances dictate. Should we decide in the future to do so, as a holding company, our ability to pay dividends and meet other obligations depends upon the receipt of dividends or other payments from our operating subsidiaries. In addition, our operating subsidiaries, from time to time, may be subject to restrictions on their ability to make distributions to us, including restrictions on the conversion of local currency into U.S. dollars or other hard currency and other regulatory restrictions.

Our common stock is illiquid and subject to price volatility unrelated to our operations.

If a market for our common stock does develop, its market price could fluctuate substantially due to a variety of factors, including market perception of our ability to achieve our planned growth, quarterly operating results of other companies in the same industry, trading volume in our common stock, changes in general conditions in the economy and the financial markets or other developments affecting us or our competitors. In addition, the stock market itself is subject to extreme price and volume fluctuations. This volatility has had a significant effect on the market price of securities issued by many companies for reasons unrelated to their operating performance and could have the same effect on our common stock.

A large number of shares may be eligible for future sale and may depress our stock price.

We may be required, under terms of future financing arrangements, to offer a large number of common shares to the public, or to register for sale by future private investors a large number of shares sold in private sales to them.

Sales of substantial amounts of common stock, or a perception that such sales could occur, and the existence of options or warrants to purchase shares of common stock at prices that may be below the then-current market price of our common stock, could adversely affect the market price of our common stock and could impair our ability to raise capital through the sale of our equity securities, either of which would decrease the value of any earlier investment in our common stock.

Item 1B. Unresolved Staff Comments

As a “smaller reporting company”, we are not required to provide the information required by this Item.

Item 2. Properties

Our offices are currently located at 3020 Old Ranch Parkway, Suite 300, Seal Beach, CA 90740 and our telephone number is (562) 799-5588. We currently have a month to month lease for this space at the rate $175 per month. As of the date of this filing, we have not sought to move or change our office site as our space is adequate to meet our needs. We intend to secure additional office space for our planned medical device business. We do not own any real property.

Quinlan Lease

On December 15, 2011, we closed the acquisition of a 2.5% interest in the Quinlan Lease from Wise Oil and Gas LLC, with the option to increase that interest to 10%. On December 23, 2011 we closed an additional 2.5% for a total of 5%. The cost of 1% of interest in the Quinlan Lease is $15,616. The Quinlan Lease is located in Pottawatomie County, Oklahoma, within the NE Shawnee Field Township 11 North, Range 4 East. The Quinlan 1, 2, 3 and 4 wells are all located within Section 19. The four wells lie between the Nemaha ridge to the west and then on to the west flank of the Seminloe-Cushing ridge (Hunton Uplift) to the east and north of Pauls Valley. On December 23, 2011 we closed an additional 2.5% for a total of 5%.

The Quinlan Lease lies within the NE Shawnee Field in Sections 13 and 24, Township 11 North, Range 4 East and Sections 18 and 19, Township 11 North, Range 5 East, Pottawatomie County, Oklahoma, and is approximately 11 miles north and east of Shawnee near the junction of State Highway 9A and Interstate I40 East. The Quinlan’s #1, #2, #3, and #4 (the salt water well) all lie in Section 19 of the above township and range and are in the southern most portion of the Central Oklahoma Platform. The Central Oklahoma Platform is located between two large sedimentary basins, the Anadarko Basin to the west and the Arkoma Basin to the east and southeast. The field with the four wells lie between the Nemaha Ridge to the west and then on to west flank of the Seminole-Cushing Ridge (Hunton Uplift) to the east and north of the Pauls Valley Uplift. The forces responsible for creating regional structures in the Ordovician appear to have begun in the middle Devonian epeirogeny. At this time, uplift occurred from the northeast, creating a regional dip to the southwest in the Hunton Limestone and older formations; therefore, with associated faulting with these uplifts allowed these ancient structures to accumulate oil reserves. The Wilzetta Fault occurred during this major uplift period and is a major fault system trending Northeast-Southwest and extending many miles both to the north and south of the NE Shawnee Field and is considered to be the west boundary fault to the field. Specifically, the field appears to be trapping oil in several faulted anticlinal features with production being reflected in the Hunton Limestone, Viola Limestone, and the first Wilcox Sand.

The Quinlan #1 was originally open hole completed in the first Wilcox Sandstone from 4,778' to 4,782'. The Simpson Dolomite from 4,742' to 4,750' and the Viola Limestone from 4,726' to 4,732' were tested several years later. Later production from the Quinlan #1 was documented producing an oil cut from 8 - 15%, (i.e. 100 barrels of total volume = 8 to 15 barrels are oil) on a daily basis from the first Wilcox Sandstone (primary objective), Viola Limestone and Simpson Dolomite (second objective). Finally, the Hunton Limestone formation was perforated and produced on a forty acre spacing pattern and was also perforated in the Quinlan #2. Since November 2009 when the well was purchased by Nitro Petroleum Inc., the Quinlan #1 has produced 13,946 barrels of oil from the Hunton Limestone.

The Quinlan #2 was originally drilled to the base of the Simpson Dolomite formation and completed in the Hunton Limestone. The Hunton Limestone was perforated from 4,594' to 4,604'. In 1976, the well was deepened to the first Wilcox and perforated in the Viola Limestone from 4,720' to 4,733' and the Simpson Dolomite from 4,756' to 4,762'. In February of 2011, the well was installed with a 70HP down-hole test submersible pump which was recently removed after a 90 day interval resulting in an average daily production rate of 13 barrels of oil with 1000 barrels of saltwater. The test pump was removed from the wellbore on May 17, 2011 and re-equipped the following day with a permanent 120HP down-hole submersible pump . Quinlan #2 has been totally re-equipped during 2012, and is currently producing 17 to 21 bbls per day.

The Quinlan #3 was tested in the Hunton Limestone and proved to be uneconomical due to a very low oil production rate with heavy water production. Quinlan #3 has been totally re-equipped during 2012, and is currently producing 13 to17 bbls per day.

The Quinlan #4 was the last well to be drilled in the field with the goal of finding the Hunton Limestone productive. Unfortunately, the down dip Hunton Limestone had incurred a facies change becoming heavily dolomitized with very low crystalline porosity. The first Wilcox Sandstone was tested after logs indicated a productive interval with a contradicting sample evaluation. Eventual testing results indicated fresh water had been injected into the zone from adjacent well without being reported to the proper authorities thus creating anonymous log inferences. The well was completed as a salt water field disposal well in the first Wilcox Sandstone which subsequently improved the overall field economics.

Summary of Estimated Oil and Gas Reserves as of Fiscal-Year End

We do not have any audited or independently verified figures for production or reserve reporting for the Quinlan property. We currently own a 10% interest in the Quinlan Leases.

Current Status of Working Interest

We currently own a 10% interest in the Quinlan Leases. As at the date of this report we have been invoiced for approximately $58,300 in lease operating expenses related to the Quinlan wells. This amount remains unpaid. Our failure to pay the outstanding amounts entitles the lease holder to foreclose on our working interest. We are actively seeking purchasers to assume our working interest and related liabilities.

Operator

Wise Oil and Gas is the operator of the Quinlan Lease. Wise Oil and Gas has been a fully licensed oil and gas operator since 1989 in the State of Oklahoma. Wise Oil and Gas have owned and operated wells throughout the State of Oklahoma, and continue to do so, since 1989. Wise Oil and Gas is the operator of our company’s working interest in the Quinlan project. Larry Wise has extensive oil and gas operating experience. Mr. Wise worked as a junior field engineer with Phillips 66 Petroleum Company 1977-1979. From 1979-1982 he worked for Jerry Scott Company as completion superintendent overseeing 14 drilling rigs and over 300 producing properties; 1982-1988 with JOMC Oil Co; 1988-1993 with Texas United Petroleum and 1993-1999 with Pottawatomie County Energy serving as president, fund raiser and chief operating officer for all three companies. From 1999 through to 2006 he operated Wise Oil and Gas Company, LLC and served as an independent engineering consultant responsible for all operations of Morris E. Stewart Oil Company, OKC, OK., Kirrie Oil Company, OKC, OK., HoCo, Inc. Oil Company, Wichita Falls, TX., and Buccaneer Energy Corporation, Tampa Bay, FL.

Acreage

The following table shows our gross and net acreage position on the Quinlan Lease as of January 31, 2014. Please note that we hold a total of 10% turnkey working interest in the property.

Property	Gross Acreage (developed)		Net Acreage (developed)		Gross Acreage (undeveloped)		Net Acreage (undeveloped)

Quinlan Lease		120		12		80		8

Item 3. Legal Proceedings

We know of no material, existing or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which our director, officer or any affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

Item 4. Mine Safety Disclosures

Not applicable.

PART II

Item 5. Market for the Company’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

On October 12, 2006, our common stock was listed for quotation on the Over-the-Counter Bulletin Board under the symbol OVCR. Our stock did not begin trading until February 23, 2012. On August 12, 2008, we changed our name from “Oliver Creek Resources Inc.” to “Independence Energy Corp.”. The name change became effective with the Over-the-Counter Bulletin Board at the opening for trading on August 12, 2008 under the new stock symbol “IDNG”.

The following table sets forth the high and low bid information for our common stock obtained from Stockwatch and reflects inter-dealer prices, without retail mark-up, markdown or commission, and may not necessarily represent actual transactions.

The high and low bid prices of our common stock for the periods indicated below are as follows:

OTC Bulletin Board(1)
Quarter Ended	High		Low

January 31, 2014	$	0.0099	$	0.0025
October 31, 2013	$	0.008	$	0.0034
July 31, 2013	$	0.0125	$	0.0045
April 30, 2013	$	0.04	$	0.0027
January 31, 2013	$	0.012	$	0.003
October 31, 2012	$	0.042	$	0.0051
July 31, 2012	$	4.83	$	0.0275
April 30, 2012	$	1.86		Nil
January 31, 2012(1)		Nil		Nil

·	Our stock was first quoted for trading on the OTC Bulletin Board on October 12, 2006, the first trade did not occur until February 23, 2012.

Record Holders

As of April 28, 2014, an aggregate of 345,188,164 shares of our common stock were issued and outstanding and there were approximately 40 shareholders of record of our common stock.

Our common shares are issued in registered form. Holladay Stock Transfer, 2939 N 67th Pl # C, Scottsdale, AZ 85251-6015 (telephone number (480) 481-3940) is the registrar and transfer agent for our common shares.

Recent Sales of Unregistered Securities

On March 4, 2014, we issued 10,714,286 common shares to Asher Enterprises, Inc. for the conversion of $15,000 of a convertible debenture.

On March 20, 2014, we issued 12,153,846 common shares to Asher Enterprises, Inc. for the conversion of $15,800 of a convertible debenture.

On March 24, 2014, we issued 4,346,154 common shares to Asher Enterprises, Inc. for the conversion of $5,650 of a convertible debenture.

On March 25, 2014, we issued 8,330,769 common shares to Asher Enterprises, Inc. for the conversion of $10,830 of a convertible debenture and accrued interest.

On April 3, 2014, we issued 15,625,000 common shares to Asher Enterprises, Inc. for the conversion of $18,750 of convertible debenture, as noted in Note 4.

On April 8, 2014, we issued 12,541,667 common shares to Asher Enterprises for the conversion of $15,050 of a convertible debenture and accrued interest.

Each of the above described issuances to Asher Enterprises Inc. was made in reliance on Rule 506 of Regulation D of the Securities Act of 1933.

On March 31, 2014, we entered into an asset purchase agreement with American Medical Distributors, LLC pursuant to which we issued an aggregate of 152,172,287 common shares to 4 investors. These securities were issued to 3 U.S. persons in reliance on Rule 506 of Regulation D of the Securities Act of 1933 and 1 non-U.S. person in reliance on Regulation S the Securities Act of 1933.

Except as noted above, we did not sell any equity securities which were not registered under the Securities Act during the year ended January 31, 2014 that were not otherwise disclosed in our registration statement on Form SB-2, Quarterly Reports on Form 10-Q or our Current Reports on Form 8-K filed during the year ended January 31, 2014.

Dividend Policy

We have not paid any cash dividends on our common stock and have no present intention of paying any dividends on the shares of our common stock. Our current policy is to retain earnings, if any, for use in our operations and in the development of our business. Our future dividend policy will be determined from time to time by our board of directors.

Equity Compensation Plan Information

We do not have in effect any compensation plans under which our equity securities are authorized for issuance and we do not have any outstanding stock options.

Purchase of Equity Securities by the Issuer and Affiliated Purchasers

We did not purchase any of our shares of common stock or other securities during our fourth quarter of our fiscal year ended January 31, 2014.

Item 6. Selected Financial Data

As a “smaller reporting company” we are not required to provide the information required by this Item.

Item 7. Management's Discussion and Analysis or Plan of Operation

The following discussion should be read in conjunction with our audited financial statements and the related notes for the years ended January 31, 2014 and 2013 that appear elsewhere in this annual report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed below and elsewhere in this annual report, particularly in the section entitled "Risk Factors" beginning on page 14 of this annual report.

Our audited financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

Working Capital

	January 31, 2014 $			January 31, 2013 $

Current Assets		11,656			48,835
Current Liabilities		362,725			216,830
Working Capital (Deficit)		(351,069	)		(167,995	)

Cash Flows

	Year ended January 31, 2014 $			Year ended January 31, 2013 $

Cash Flows from (used in) Operating Activities		(161,943	)		(73,540	)
Cash Flows from (used in) Investing Activities		-			(485,015	)
Cash Flows from (used in) Financing Activities		133,000			580,000
Net Increase (decrease) in Cash During Period		(28,943	)		21,445

Operating Revenues

For the period from November 30, 2005 (date of inception) to January 31, 2014, our company did not earn any operating revenues.

Operating Expenses and Net Loss

Operating expenses for the year ended January 31, 2014 was $175,266 compared with $135,719 for the year ended January 31, 2013. The increase of $39,547 was due to an increase in general and administrative costs relating to an increase in management fees during the year of $40,000, and consulting fees of $20,000 offset by a decrease in investor relations of $22,770 as our company did not warrant the need for investor relations cost during the year, and a decrease in professional fees of $5,651 as our company had lower accounting and legal fees as compared to prior years.

For the year ended January 31, 2014, our company incurred a net loss of $543,622 or $nil per share compared with $135,719 or $nil per share for the year ended January 31, 2013. In addition to operating expenses, our company incurred accretion and interest expense of $19,934 relating to the $45,000 of convertible note debentures which are unsecured, bears interest at 8% per annum, and due on April 17, 2014 and the $32,500 convertible note debenture, which is unsecured, bears interest at 8% per annum, and due on June 19, 2014. The $45,000 note is convertible into shares of common stock 180 days after the date of issuance (January 11, 2014) at a conversion rate of 58% of the average of the three lowest closing bid prices of our company’s common stock for the ten trading days ending one trading day prior to the date the conversion notice is sent by the holder to our company. The $32,500 note is convertible into shares of common stock 180 days after the date of issuance (March 16, 2014) at a conversion rate of 58% of the average of the three lowest closing bid prices of our company’s common stock for the ten trading days ending one trading day prior to the date the conversion notice is sent by the holder to our company. Subsequent to January 31, 2014, the remaining principal and accrued interest on all convertible note debentures were converted into common shares of our company. Furthermore, our company recorded a gain on the forgiveness of a loan for $48,284, and impairment loss of $335,284 relating to our company’s decision to not renew the Coleman County leases, and a gain on the change in fair value of the derivative liability of $54,438 based on the mark-to-market of the fair value of the floating rate conversion feature in the convertible debentures.

Liquidity and Capital Resources

As at January 31, 2014, our company had cash of $7,292 compared with $36,235 at January 31, 2013. The decrease in cash was attributed to the fact that our company obtained additional financing from the issuance of convertible debentures during the year and used the proceeds for operating expenditures

Our company had total assets at January 31, 2014 of $220,334 compared with $587,260 at January 31, 2013. Overall, cash decreased by $28,943 and oil and gas properties decreased by $329,747 due to the impairment of the Coleman County properties for $335,284.

At January 31, 2014, our company had total liabilities of $362,725 compared with $216,830 at January 31, 2013. The increase in total liabilities was attributed to an increase in accounts payable and accrued liabilities of $12,824, and $35,834 for the liability relating to the convertible debentures, net of unamortized discount of $41,666, and derivative liability of $97,237 for the fair value of the beneficial conversion feature of the convertible debentures.

Cashflow from Operating Activities

During the year ended January 31, 2014, our company used cash of $161,943 for operating activities compared with $73,540 during the year ended January 31, 2013. The increase in cash used for operating activities was attributed to proceeds received from the issuance of convertible debentures which were used to repay outstanding obligations incurred in day-to-day operations of our company.

Cashflow from Investing Activities

During the year ended January 31, 2014, our company did not have any investing activities compared with the use of $485,015 during the year ended January 31, 2013 for the acquisition of oil and gas properties.

Cashflow from Financing Activities

During the year ended January 31, 2014, our company received $133,000 in financing from the issuance of convertible debentures. Our company received proceeds from convertible debentures for $46,000 which is unsecured, bears interest at 6% per annum, and due on April 5, 2016, $57,000 from the issuance of a convertible debenture which is unsecured, bears interest at 8% per annum, and due on April 17, 2014, and $32,500 from the issuance of a convertible debenture which is unsecured, bears interest at 8% per annum, and due on June 19, 2014, less financing fees which were deducted from the proceeds before being disbursed to our company. Our company received $580,000 during the period ended October 31, 2013 from the issuance of common shares.

Going Concern

We have not attained profitable operations and are dependent upon obtaining financing to pursue any extensive acquisitions and activities. For these reasons, our auditors stated in their report on our audited financial statements that they have substantial doubt that we will be able to continue as a going concern without further financing.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Future Financings

We will continue to rely on equity sales of our common shares in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our operations and other activities.

Critical Accounting Policies

Our financial statements and accompanying notes have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

We regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. A complete summary of these policies is included in the notes to our financial statements. In general, management's estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from those estimates made by management.

Oil and Gas Properties

Our company utilizes the full-cost method of accounting for petroleum and natural gas properties. Under this method, our company capitalizes all costs associated with acquisition, exploration, and development of oil and natural gas reserves, including leasehold acquisition costs, geological and geophysical expenditures, lease rentals on undeveloped properties and costs of drilling of productive and non-productive wells into the full cost pool on a country-by-country basis. When our company obtains proven oil and gas reserves, capitalized costs, including estimated future costs to develop the reserves proved and estimated abandonment costs, net of salvage, will be depleted on the units-of-production method using estimates of proved reserves. The costs of unproved properties are not amortized until it is determined whether or not proved reserves can be assigned to the properties. Until such determination is made, our company assesses annually whether impairment has occurred, and includes in the amortization base drilling exploratory dry holes associated with unproved properties.

Our company applies a ceiling test to the capitalized cost in the full cost pool. The ceiling test limits such cost to the estimated present value, using a ten percent discount rate, of the future net revenue from proved reserves based on current economic and operating conditions. Specifically, our company computes the ceiling test so that capitalized cost, less accumulated depletion and related deferred income tax, do not exceed an amount (the ceiling) equal to the sum of: The present value of estimated future net revenue computed by applying current prices of oil and gas reserves (with consideration of price changes only to the extent provided by contractual arrangements) to estimated future production of proved oil and gas reserves as of the date of the latest balance sheet presented, less estimated future expenditures (based on current cost) to be incurred in developing and producing the proved reserves computed using a discount factor of ten percent and assuming continuation of existing economic conditions; plus the cost of property not being amortized; plus the lower of cost or estimated fair value of unproven properties included in the costs being amortized; less income tax effects related to differences between the book and tax basis of the property. For unproven properties, our company excludes from capitalized costs subject to depletion, all costs directly associated with the acquisition and evaluation of the unproved property until it is determined whether or not proved reserves can be assigned to the property. Until such a determination is made, our company assesses the property at least annually to ascertain whether impairment has occurred. In assessing impairment our company considers factors such as historical experience and other data such as primary lease terms of the property, average holding periods of unproved property, and geographic and geologic data. Our company adds the amount of impairment assessed to the cost to be amortized subject to the ceiling test.

Recently Issued Accounting Pronouncements

Our company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and our company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

As a “smaller reporting company” we are not required to provide the information required by this Item.

Item 8. Financial Statements and Supplementary Data

Independence Energy Corp.

(An Exploration Stage Company)

January 31, 2014

Index

Report of Independent Registered Public Accounting Firm	24

Condensed Balance Sheets	25

Condensed Statements of Operations	26

Condensed Statements of Cash Flows	27

Condensed Statements of Stock holders’ (Deficit) Equity	28

Notes to the Condensed Financial Statements	29

PLS CPA, A Professional Corporation

t 4725 MERCURY STREET SUITE 210 t SAN DIEGO t CALIFORNIA 92111t

t TELEPHONE (858)722-5953 t FAX (858) 761-0341 t FAX (858) 433-2979

t E-MAIL changgpark@gmail.com t

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders

Independence Energy Corp.

We have audited the accompanying balance sheets of Independence Energy Corp. (An Exploration Stage “Company”) as of January 31, 2014 and 2013 and the related statements of operations, changes in shareholders’ equity and cash flows for the years then ended, and for the period from November 30, 2005 (inception) to January 31, 2014. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Independence Energy Corp. as of January 31, 2014 and 2013, and the result of its operations and its cash flows for the years then ended and for the period from November 30, 2005 (inception) to January 31, 2014 in conformity with U.S. generally accepted accounting principles.

The financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company’s losses from operations raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ PLS CPA

PLS CPA, A Professional Corporation

May 1, 2014

San Diego, CA. 92111

Independence Energy Corp.

(An Exploration Stage Company)

Balance Sheets

(expressed in U.S. dollars)

	January 31, 2014 $			January 31, 2013 $
ASSETS

Current Assets
Cash		7,292			36,235
Prepaid expenses and deposits		3,100			12,600
Deferred financing charge		1,264			–

Total Current Assets		11,656			48,835

Oil & gas properties		208,678			538,425

Total Assets		220,334			587,260


LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities
Accounts payable and accrued liabilities		72,957			60,133
Convertible debenture, net of unamortized discount of $41,666 and $nil, respectively		35,834			–
Loans payable		156,697			156,697
Derivative liability		97,237			–

Total Liabilities		362,725			216,830

Stockholders’ Equity
Common Stock
Authorized: 375,000,000 common shares, with a par value of $0.001 per share Issued and outstanding: 129,304,155 and 121,804,155 common shares, respectively		129,304			121,804

Additional paid-in capital		541,497			518,196

Deficit accumulated during the exploration stage		(813,192	)		(269,570	)

Total Stockholders’ Equity		(142,391	)		370,430

Total Liabilities and Stockholders’ Equity		220,334			587,260

(The accompanying notes are an integral part of these financial statements)

Independence Energy Corp.

(An Exploration Stage Company)

Statements of Operations

(expressed in U.S. dollars)

	Year ended January 31, 2014 $			Year ended January 31, 2013 $			Accumulated from November 30, 2005 (date of inception) to January 31, 2014 $

Revenue		–			–			–

Operating Expenses
General and administrative		128,395			83,197			287,487
Professional fees		46,871			52,522			157,349

Total Operating Expenses		175,266			135,719			444,836

Net Operating Loss		(175,266	)		(135,719	)		(444,836	)

Other Income (Expense)
Accretion expense		(19,934	)		–			(19,934	)
Amortization of deferred financing charges		(1,236	)		–			(1,236	)
Gain on forgiveness of loan		48,284			–			48,284
Gain on change in fair value of derivative liability		(54,438	)		–			(54,438	)
Impairment of oil and gas property		(335,284	)		–			(335,284	)
Interest expense		(5,748	)		–			(5,748	)

Total Other Income (Expense)		(368,356	)		–			(368,356	)

Net Loss		(543,622	)		(135,719	)		(813,192	)

Net Loss Per Share, Basic and Diluted		–			–

Weighted Average Shares Outstanding		121,886,347			121,490,584

(The accompanying notes are an integral part of these financial statements)

Independence Energy Corp.

(An Exploration Stage Company)

Statements of Stockholders’ Equity (Deficit)

(expressed in U.S. dollars)

					Additional
	Common Stock				Paid-In			Accumulated
	Shares		Par Value		Capital			Deficit			Total
	#		$		$			$			$

Balance – November 30, 2005 (date of inception)		–		–		–			–			–

Issuance of shares for cash		60,000,000		60,000		(50,000	)		–			10,000

Net loss for the period		–		–		–			(8	)		(8	)
		–		–
Balance – January 31, 2006		60,000,000		60,000		(50,000	)		(8	)		9,992

Issuance of shares for cash		60,000,000		60,000		(10,000	)		–			50,000

Net loss for the year		–		–		–			(14,302	)		(14,302	)

Balance – January 31, 2007		120,000,000		120,000		(60,000	)		(14,310	)		45,690

Net loss for the year		–		–		–			(16,032	)		(16,032	)

Balance – January 31, 2008		120,000,000		120,000		(60,000	)		(30,342	)		29,658

Net loss for the year		–		–		–			(24,790	)		(24,790	)

Balance – January 31, 2009		120,000,000		120,000		(60,000	)		(55,132	)		4,868

Net loss for the year		–		–		–			(13,583	)		(13,583	)

Balance – January 31, 2010		120,000,000		120,000		(60,000	)		(68,715	)		(8,715	)

Net loss for the year		–		–		–			(13,719	)		(13,719	)

Balance – January 31, 2011		120,000,000		120,000		(60,000	)		(82,434	)		(22,434	)

Net loss for the year		–		–		–			(51,417	)		(51,417	)

Balance – January 31, 2012		120,000,000		120,000		(60,000	)		(133,851	)		(73,851	)

Issuance of shares for cash		1,804,155		1,804		578,196			–			580,000

Net loss for the year		–		–		–			(135,719	)		(135,719	)
		–		–
Balance – January 31, 2013		121,804,155		121,804		518,196			(269,570	)		370,430

Fair value of beneficial conversion feature recorded on issuance of convertible debt		–		–		18,801			–			18,801

Conversion of debt		7,500,000		7,500		4,500			–			12,000

Net loss for the year		–		–		–			(543,622	)		(543,622	)
		–		–
Balance – January 31, 2014		129,304,155		129,304		541,497			(813,192	)		(142,391	)

(The accompanying notes are an integral part of these financial statements)

Independence Energy Corp.

(An Exploration Stage Company)

Statements of Cash Flows

(expressed in U.S. dollars)

	Year ended January 31, 2014 $			Year ended January 31, 2013 $			Accumulated from November 30, 2005 (date of inception) to January 31, 2014 $
Operating Activities
Net loss		(543,622	)		(135,719	)		(813,192	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of discount on convertible debenture		19,934			–			19,934
Amortization of deferred financing charges		1,236			–			1,236
Gain on forgiveness of loan		(48,284	)		–			(48,284	)
Gain on change in fair value of derivative liability		54,438			–			54,438
Impairment of oil and gas property		335,284						335,284
Changes in operating assets and liabilities:
Amounts receivable		–			1,607			–
Prepaid expense and deposits		9,500			10,463			(3,100	)
Accounts payable and accrued liabilities		9,571			50,784			69,704
Due to a related party		–			(675	)		–

Net Cash Used in Operating Activities		(161,943	)		(73,540	)		(383,980	)

Investing Activities
Oil and gas property expenditures		–			(485,015	)		(538,425	)

Net Cash Used in Investing Activities		–			(485,015	)		(538,425	)

Financing activities
Proceeds from issuance of common stock		–			580,000			640,000
Proceeds from issuance of convertible debenture		133,000			–			133,000
Proceeds from loans payable		–			–			156,697
Proceeds from loans payable to director		–			–			33,000
Repayment of loans payable to director		–			–			(33,000	)

Net Cash Provided by Financing Activities		133,000			580,000			929,697

Increase (Decrease) in Cash		(28,943	)		21,445			7,292

Cash, Beginning of Period		36,235			14,790			–

Cash, End of Period		7,292			36,235			7,292

Non-cash investing and financing activities:
Beneficial conversion feature of convertible debenture		18,801			–			18,801

Supplemental Disclosures
Interest paid		–			–			–
Income tax paid		–			–			–

(The accompanying notes are an integral part of these financial statements)

Independence Energy Corp.

(An Exploration Stage Company)

Notes to the Financial Statements

(expressed in U.S. dollars)

1. Nature of Operations and Continuance of Business

Independence Energy Corp. (the "Company") was incorporated in the State of Nevada on November 30, 2005. The Company was organized to explore natural resource properties in the United States. The Company is an exploration stage company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915, Development Stage Entities.

Going Concern

These financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has generated no revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future. As of January 31, 2014, the Company had a working capital deficit of $351,069 and an accumulated deficit of $813,192. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2. Summary of Significant Accounting Policies

a)	Basis of Presentation

These financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in US dollars. The Company’s fiscal year-end is January 31.

b)	Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States and requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to valuation and impairment of oil and gas properties, asset retirement obligations, fair value of share-based payments, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

c)	Basic and Diluted Net Loss Per Share

The Company computes net loss per share in accordance with ASC 260, Earnings Per Share, which requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net loss available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. As of January 31, 2014, the Company had 29,463,117 (2013 – nil) potentially dilutive shares.

Independence Energy Corp.

(An Exploration Stage Company)

Notes to the Financial Statements

(expressed in U.S. dollars)

Summary of Significant Accounting Policies (continued)

d)	Oil and Gas Property Costs

The Company utilizes the full-cost method of accounting for petroleum and natural gas properties. Under this method, the Company capitalizes all costs associated with acquisition, exploration, and development of oil and natural gas reserves, including leasehold acquisition costs, geological and geophysical expenditures, lease rentals on undeveloped properties and costs of drilling of productive and non-productive wells into the full cost pool on a country-by-country basis. When the Company obtains proven oil and gas reserves, capitalized costs, including estimated future costs to develop the reserves proved and estimated abandonment costs, net of salvage, will be depleted on the units-of-production method using estimates of proved reserves. The costs of unproved properties are not amortized until it is determined whether or not proved reserves can be assigned to the properties. Until such determination is made, the Company assesses annually whether impairment has occurred, and includes in the amortization base drilling exploratory dry holes associated with unproved properties.

The Company applies a ceiling test to the capitalized cost in the full cost pool. The ceiling test limits such cost to the estimated present value, using a ten percent discount rate, of the future net revenue from proved reserves based on current economic and operating conditions. Specifically, the Company computes the ceiling test so that capitalized cost, less accumulated depletion and related deferred income tax, do not exceed an amount (the ceiling) equal to the sum of: The present value of estimated future net revenue computed by applying current prices of oil and gas reserves (with consideration of price changes only to the extent provided by contractual arrangements) to estimated future production of proved oil and gas reserves as of the date of the latest balance sheet presented, less estimated future expenditures (based on current cost) to be incurred in developing and producing the proved reserves computed using a discount factor of ten percent and assuming continuation of existing economic conditions; plus the cost of property not being amortized; plus the lower of cost or estimated fair value of unproven properties included in the costs being amortized; less income tax effects related to differences between the book and tax basis of the property. For unproven properties, the Company excludes from capitalized costs subject to depletion, all costs directly associated with the acquisition and evaluation of the unproved property until it is determined whether or not proved reserves can be assigned to the property. Until such a determination is made, the Company assesses the property at least annually to ascertain whether impairment has occurred. In assessing impairment the Company considers factors such as historical experience and other data such as primary lease terms of the property, average holding periods of unproved property, and geographic and geologic data. The Company adds the amount of impairment assessed to the cost to be amortized subject to the ceiling test.

e)	Beneficial Conversion Features

From time to time, the Company may issue convertible notes that may contain an imbedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.

f)	Derivative Liability

From time to time, the Company may issue equity instruments that may contain an embedded derivative instrument which may result in a derivative liability. A derivative liability exists on the date the equity instrument is issued when there is a contingent exercise provision. The derivative liability is records at is fair value calculated by using an option pricing model such as a multi-nominal lattice model. The fair value of the derivative liability is then calculated on each balance sheet date with the corresponding gains and losses recorded in the consolidated statement of operations.

Independence Energy Corp.

(An Exploration Stage Company)

Notes to the Financial Statements

(expressed in U.S. dollars)

2.Summary of Significant Accounting Policies (continued)

g)	Income Taxes

Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740, Income Taxes, as of its inception. Pursuant to ASC 740, the Company is required to compute tax asset benefits for net operating losses carried forward. The potential benefits of net operating losses have not been recognized in these financial statements because the Company cannot be assured it is more likely than not it will utilize the net operating losses carried forward in future years.

h)	Comprehensive Loss

ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at January 31, 2014 and 2013, the Company has no items that represent comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements.

i)	Financial Instruments

Pursuant to ASC 820, Fair Value Measurements and Disclosures, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value:

Level 1

Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2

Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3

Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, and amounts due to related parties. Pursuant to ASC 820 and 825, the fair value of our cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.

j)	Recent Accounting Pronouncements

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial statements.

Independence Energy Corp.

(An Exploration Stage Company)

Notes to the Financial Statements

(expressed in U.S. dollars)

3. Oil and Gas Properties

On December 15, 2011, the Company acquired a 2.5% interest in four wells in the Quinlan Lease (“Quinlan”) from Wise Oil and Gas LLC (“Wise”), with the option to increase the interest to 10%. On December 23, 2011, the Company acquired an additional 2.5% interest in Quinlan. Quinlan is located in Pottawatomie County, Oklahoma. On March 1, 2012, the Company acquired an additional 5% interest in Quinlan in exchange for $78,080, bringing the Company’s total interest to 10%.

On March 29, 2012, the Company acquired a 5% interest in a 70% net revenue interest of properties in Coleman County, Texas for $115,000. On June 28, 2012, the Company amended the original agreement to acquire a 7% interest in a 75% net revenue interest in the properties for an additional payment of $47,000, and replaced the terms of the original agreement. Refer to Note 3(e).

c)	On May 29, 2012, the Company acquired a 2.5% interest in a 70% net revenue interest in two oil and gas wells and approximately 20 acres of land surrounding the area in Coleman County, Texas for $82,500. Refer to Note 3(e).

d)	On June 8, 2012, the Company acquired a 12.5% interest, with an option to acquire an additional 12.5% interest, for $90,785. The properties comprise an area of 2,421 acres in Coleman County, Texas. Refer to Note 3(e).

On February 28, 2013, the Company entered into a Compromise, Settlement and Property Exchange Agreement with MontCrest Energy, Inc. and Black Strata, LLC. Pursuant to the terms of the agreement, the Company transferred its working interests in Coleman County with a book value of $335,285, in consideration of a 100% interest in approximately 1,400 acres of the Coleman County South Lease held by Black Strata, LLC. During the year ended January 31, 2014, the Company elected not to renew the working interest and recorded a full impairment of the book value.

4. Convertible Debentures

On April 5, 2013, the Company entered into a convertible promissory note agreement for $46,000. Pursuant to the agreement, the loan is unsecured, bears interest at 6% per annum, and is due on April 5, 2016. The note is convertible into common shares of the Company at any time at a conversion price of $0.01 at the option of the note holder.

As at January 31, 2014, the Company owed $2,284 (2013 - $nil) of accrued interest. On January 31, 2014, the loan holder forgave the convertible promissory note and all accrued interest, resulting in a gain on forgiveness of loan of $48,284.

On July 15, 2013, the Company issued a $57,000 convertible note which is unsecured, bears interest at 8% per annum and due on April 17, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (January 11, 2014) at a conversion rate of 58% of the average of the three lowest closing bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. Upon an event of default, the entire principal balance and accrued interest outstanding is due immediately, and interest shall accrue on the unpaid principal balance at 22% per annum. As at January 31, 2014, accrued interest of $2,488 (2013 - $nil) has been recorded in accounts payable and accrued liabilities. During the year ended January 31, 2014, the Company issued 7,500,000 shares of common stock for the conversion of $12,000.

In accordance with ASC 470-20, “Debt with Conversion and Other Options”, the Company recognized the intrinsic value of the embedded beneficial conversion feature of $57,000 and an equivalent discount which will be charged to operations over the term of the convertible note. During the year ended January 31, 2014, the Company had amortized $16,603 (2013 - $nil) of the debt discount to interest expense. As at January 31, 2014, the carrying value of the debenture was $3,334 (2013 - $nil).

Independence Energy Corp.

(An Exploration Stage Company)

Notes to the Financial Statements

(expressed in U.S. dollars)

4. Convertible Debentures (continued)

On September 17, 2013, the Company issued a $32,500 convertible note which is unsecured, bears interest at 8% per annum and due on June 19, 2014. The Company received $30,000, net of issuance fee of $2,500. The note is convertible into shares of common stock 180 days after the date of issuance (March 16, 2014) at a conversion rate of 58% of the average of the three lowest closing bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date the conversion notice is sent by the holder to the Company. Upon an event of default, the entire principal balance and accrued interest outstanding is due immediately, and interest shall accrue on the unpaid principal balance at 22% per annum. As at January 31, 2014, accrued interest of $976 (2013 - $nil) has been recorded in accounts payable and accrued liabilities.

5. Loan Payable

As of January 31, 2014, the Company had loan payable of $156,697 (2013 - $156,697) owing to an unrelated third party. The amount owing is non-interest bearing, unsecured and due on demand.

6. Fair Value Measurements

On a recurring basis, we measure certain financial assets and liabilities based upon the fair value hierarchy as described in the Company’s significant accounting policies in Note 2. The following table presents information about the Company’s liabilities measured at fair value as of January 31, 2014.

	Level 1		Level 2		Level 3		Fair Value at January 31, 2014
Liabilities
Derivative liability		-		-	$	97,237	$	97,237

The fair value changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), relate solely to the derivative liability as follows:

Balance as of January 31, 2013	$	-
Derivative liability recorded		97,713
Adjustment due to conversion		(14,201	)
Fair value adjustment		13,724
Balance as of January 31, 2014	$	97,236

7. Derivative Financial Instruments

The balance sheet caption derivative liability consists of derivative features embedded in convertible debentures including the conversion feature. These derivative financial instruments are indexed to an aggregate of 29,463,117 shares of the Company’s common stock as of January 31, 2014 and are carried at fair value. The balance at January 31, 2014 is $97,236.

The valuation of the derivative liability is determined using a Black-Scholes Merton Model because that model embodies all of the relevant assumptions that address the features underlying these instruments. Significant assumptions used in the Black-Scholes models at January 31, 2014 include the following:

Independence Energy Corp.

(An Exploration Stage Company)

Notes to the Financial Statements

(expressed in U.S. dollars)


Risk-free interest rate		0.05	%
Estimated volatility		279.54	%
Dividend rate	None
Estimated term in years		0.21

8.	Related Party Transactions

During the period ended January 31, 2014, the Company incurred $76,000 (2013 - $36,000) to the President and CEO of the Company for management services. As of January 31, 2014, the Company had $3,100 (January 31, 2013 - $10,500) in prepaid expense for management fees paid to the President and CEO of the Company.

9.	Income Taxes

The Company has $451,819 of net operating losses carried forward to offset taxable income in future years which expire commencing in fiscal 2026. The income tax benefit differs from the amount computed by applying the US federal income tax rate of 34% to net loss before income taxes. As at January 31, 2014, the Company had no uncertain tax positions.

	2014 $			2013 $

Net loss before taxes		(543,622	)		(135,719	)
Statutory rate		34	%		34	%

Computed expected tax recovery		(184,831	)		(46,144	)
Valuation allowance		184,831			46,144

Income tax provision		–			–

As at January 31, 2014, the Company has non-capital losses carried forward of $451,819, which are available to offset deferred years’ taxable income. These losses expire as follows:

Independence Energy Corp.

(An Exploration Stage Company)

Notes to the Financial Statements

(expressed in U.S. dollars)

			$

2026			8
2027			14,302
2028			16,032
2029			24,790
2030			13,583
2031			13,719
2032			51,417
2033			135,719
2034			182,249

			451,819

10. Subsequent Events

We have evaluated subsequent events through the date of issuance of the financial statements, and did not have any material recognizable subsequent events after January 31, 2014, excepting the following:

a)	On March 4, 2014, the Company issued 10,714,286 common shares for the conversion of $15,000 of convertible debenture as noted in Note 4.

b)	On March 20, 2014, the Company issued 12,153,846 common shares for the conversion of $15,800 of convertible debenture, as noted in Note 4.

c)	On March 24, 2014, the Company issued 4,346,154 common shares for the conversion of $5,650 of convertible debenture, as noted in Note 4.

d)	On March 25, 2014, the Company issued 8,330,769 common shares for the conversion of $10,830 of convertible debenture and accrued interest, as noted in Note 4.

e)	On March 31, 2014, the Company entered into an asset purchase agreement (the “Agreement”) with American Medical Distributors, LLC (“AMD”) where the Company acquired the assets of AMD in exchange for the issuance of 152,172,287 common shares of the Company.

f)	On April 3, 2014, the Company issued 15,625,000 common shares for the conversion of $18,750 of convertible debenture, as noted in Note 4.

g)	On April 8, 2014, the Company issued 12,541,667 common shares for the conversion of $15,050 of convertible debenture and accrued interest, as noted in Note 4.

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

There were no disagreements with our accountants related to accounting principles or practices, financial statement disclosure, internal controls or auditing scope or procedure during the two fiscal years and subsequent interim periods.

Item 9A. Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the "Exchange Act"), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer), as appropriate to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of January 31, 2014. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our chief executive officer and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer) concluded that our disclosure controls and procedures were not effective.

Management’s Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Exchange Act Rule 13a-15(f). Our company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of management, including the chief executive officer and chief financial officer (our principal executive officer, principal financial officer and principal accounting officer), our company conducted an evaluation of the effectiveness of our company’s internal control over financial reporting as of January 31, 2014 using the criteria established in “Internal Control - Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO").

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of January 31, 2014, our company determined that there were control deficiencies that constituted material weaknesses, as described below.

We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over our company’s financial statements. Currently the board of directors acts in the capacity of the audit committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

We did not maintain appropriate cash controls – As of January 31, 2014, our company has not maintained sufficient internal controls over financial reporting for the cash process, including failure to segregate cash handling and accounting functions, and did not require dual signature on our company’s bank accounts. Alternatively, the effects of poor cash controls were mitigated by the fact that our company had limited transactions in their bank accounts.

We did not implement appropriate information technology controls – As at January 31, 2014, our company retains copies of all financial data and material agreements; however there is no formal procedure or evidence of normal backup of our company’s data or off-site storage of the data in the event of theft, misplacement, or loss due to unmitigated factors.

Accordingly, our company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by our company’s internal controls.

As a result of the material weaknesses described above, management has concluded that our company did not maintain effective internal control over financial reporting as of January 31, 2014 based on criteria established in Internal Control—Integrated Framework issued by COSO.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting identified in connection with our evaluation we conducted of the effectiveness of our internal control over financial reporting as of January 31, 2014, that occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

This annual report does not include an attestation report of our company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our company’s registered public accounting firm pursuant to temporary rules of the SEC that permit our company to provide only management’s report in this annual report.

Continuing Remediation Efforts to address deficiencies in Company’s Internal Control over Financial Reporting

Once our company is engaged in a business of merit and has sufficient personnel available, then our board of directors, in particular and in connection with the aforementioned deficiencies, will establish the following remediation measures:

·	We will attempt to increase the amount of members on Our board of directors and nominate an audit committee or a financial expert in the next fiscal year, 2014- 2015.

·	We will appoint additional personnel to assist with the preparation of our company’s monthly financial reporting, including preparation of the monthly bank reconciliations.

Item 9B. Other Information

On March 31, 2014, Gregory Rotelli resigned as chief executive officer of our company.

On March 31, 2014, we appointed Howard Taylor as chief executive officer and director of our company, and Daniel Schreiber as a director of our company. Mr. Taylor will also serve as chairman of the board of directors. Our board of directors now consists of Gregory Rotelli, Howard Taylor and Daniel Schreiber. Mr. Rotelli continues to serve as president, chief financial officer, secretary and treasurer of our company.

PART III

Item 10. Directors and Executive Officers

All directors of our company hold office until the next annual meeting of the security holders or until their successors have been elected and qualified. The officers of our company are appointed by our board of directors and hold office until their death, resignation or removal from office. Our directors and executive officers, their ages, positions held, and duration as such, are as follows:

Name	Position Held with the Company	Age	Date First Elected or Appointed

Howard Taylor	Chief Executive Officer and Director	53	March 31, 2014
Gregory Rotelli	President, Chief Financial, Treasurer, Secretary and Director	53	November 30, 2011
Daniel Schreiber	Director	48	March 31, 2014

Business Experience

The following is a brief account of the education and business experience during at least the past five years of each director, executive officer and key employee of our company, indicating the person’s principal occupation during that period, and the name and principal business of the organization in which such occupation and employment were carried out.

Mr. Gregory Rotelli – President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director

Gregory Rotelli has been a director of our company since November 30, 2011. He was appointed as chief executive officer, chief financial officer, treasurer, secretary of our company on February 22, 2012 and resigned as chief executive officer on March 31, 2014. Mr. Rotelli has held leading positions in both technology startups as well as with established public companies. He has also been senior vice president of marketing for such companies as USSearch.com, a search engine technology company, and Systems Integrators (Sii), one of the largest computer hardware/software companies for major newspapers including Financial Times of London, Los Angeles Times, Le Monde of Paris and many more publications worldwide. He has over 25 years’ experience in senior management for both public and early-stage private companies, including former chief operating officer for Direct Stock Market, an online investment bank for emerging growth venture capital financing.

From July 2009 to July 2010, Mr. Rotelli was the president of Toro Ventures Inc., an oil and gas explorations company. His responsibility as president of our company included managing the day to day operations of the company.

Since January 2000, Mr. Rotelli has been a principal of Pacific Coast Capital Group, LLC, a privately owned consulting group focused on oil and gas, mining and financial services. As a consultant, Mr. Rotelli has advised and negotiated in both structured financings and early stage investments.

From March 2011 to July 2011, Mr. Rotelli was an officer and director of Razor Resources Inc., a minerals exploration company traded on the OTC Bulletin Board.

Since May 2011, Mr. Rotelli has been the president of Rostock Ventures Corporation, a resource exploration and production company engaged in the exploration, acquisition and development of mineral properties in the United States and traded on the OTC Bulletin Board. His responsibility as president of the company includes managing the day to day operations of the company.

Mr. Rotelli earned a Bachelor of Arts degree in Classics from Brown University in Rhode Island in 1982. He was deemed a Distinguished Scholar at the Regent University in Virginia, where he received his MBA in Marketing and Management in 1985. We appointed Gregory C. Rotelli as a member to our board of directors because of his experience with public companies.

Howard Taylor – Chief Executive Officer, Chairman and Director

Howard Taylor has acted as chief executive officer, chairman of the board and as a director of our company since March 31, 2014. Since 1995, Howard J. Taylor has been chief executive officer of Concorde Capital Limited, a private investment banking and consulting company focused on the sourcing, structuring, funding and management of private placements and private equity transactions. Is this capacity Mr. Taylor has overseen numerous investments and placements of transactions across a broad industry spectrum and managed public reporting and Sarbanes Oxley compliance. Bringing over 25 years capital markets experience, Mr. Taylor has held the NASD Series 7, 24 and 63 licenses, been a registered director with the SFA (UK) and is a Fellow of the Securities Institute in the United Kingdom.

Formerly, Mr. Taylor was an executive with County Natwest Securities, a leading international investment bank, and a director and compliance officer of an NASD and SFA broker dealer where he was responsible for its successful transition into investment banking. He is also a director and major shareholder of UK based Villa Care Ltd., a care home operating and property company and, since 2009, a founding group member of American Scientific Resources, a medical device company that led the way in the development of IR Thermometry. Mr. Taylor served as a director of American Scientific Resources from 2011 to 2012. He is a resident of the United Kingdom. We appointed Howard Taylor as a member to our board of directors because his extensive management and corporate finance expertise, and his experience in the medical device industry.

Daniel Schreiber – Director

Daniel Schreiber has acted as a director of our company since March 31, 2014. Since 1997 Mr. Daniel Schreiber has served as the chief executive officer and president of Avior Capital, LLC. At Avior, Mr. Schreiber sources and structures real estate and corporate finance transactions, and oversees the firm’s investment banking team. Mr. Schreiber began his career at Shearson Lehman where is he was a director council member. Mr. Schreiber is a resident of California. We appointed Daniel Schreiber as a member to our board of directors due to his corporate finance and management expertise.

Identification of Significant Employees

We have no significant. Our officers and directors provide their services to our company as independent consultants on a non-exclusive basis.

Family Relationship

There are no family relationships between any of our directors, executive officers and proposed directors or executive officers.

Involvement in Certain Legal Proceedings

To the best of our knowledge, none of our directors or executive officers has, during the past ten years:

·	been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offences);

·	had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;

been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;

·	been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or

been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Audit Committee and Audit Committee Financial Expert

Our board of directors has determined that it does not have a member of its audit committee that qualifies as an "audit committee financial expert" as defined in Item 407(d)(5)(ii) of Regulation S-K, and is "independent" as the term is used in Item 7(d)(3)(iv) of Schedule 14A under the Securities Exchange Act of 1934, as amended.

We believe that members of our board of directors are capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. We believe that retaining an independent director who would qualify as an "audit committee financial expert" would be overly costly and burdensome and is not warranted in our circumstances given the early stages of our development and the fact that we have not generated any material revenues to date. In addition, we currently do not have nominating, compensation or audit committees or committees performing similar functions nor do we have a written nominating, compensation or audit committee charter. Our directors do not believe that it is necessary to have such committees because they believe the functions of such committees can be adequately performed by the members of our board of directors.

Code of Ethics

We have adopted a Code of Business Conduct and Ethics that applies to, among other persons, members of our board of directors, our company's officers including our president, chief executive officer and chief financial officer, employees, consultants and advisors. As adopted, our Code of Business Conduct and Ethics sets forth written standards that are designed to deter wrongdoing and to promote:

·	honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

·	full, fair, accurate, timely, and understandable disclosure in reports and documents that we file with, or submit to, the Securities and Exchange Commission and in other public communications made by us;

·	compliance with applicable governmental laws, rules and regulations;

·	the prompt internal reporting of violations of the Code of Business Conduct and Ethics to an appropriate person or persons identified in the Code of Business Conduct and Ethics; and

·	accountability for adherence to the Code of Business Conduct and Ethics.

Our Code of Business Conduct and Ethics requires, among other things, that all of our company's senior officers commit to timely, accurate and consistent disclosure of information; that they maintain confidential information; and that they act with honesty and integrity.

In addition, our Code of Business Conduct and Ethics emphasizes that all employees, and particularly senior officers, have a responsibility for maintaining financial integrity within our company, consistent with generally accepted accounting principles, and federal and state securities laws. Any senior officer who becomes aware of any incidents involving financial or accounting manipulation or other irregularities, whether by witnessing the incident or being told of it, must report it to our company. Any failure to report such inappropriate or irregular conduct of others is to be treated as a severe disciplinary matter. It is against our company policy to retaliate against any individual who reports in good faith the violation or potential violation of our company's Code of Business Conduct and Ethics by another.

Our Code of Business Conduct and Ethics was filed with the Securities and Exchange Commission as Exhibit 14.1 to our annual report on Form 10-K filed on May 15, 2012. We will provide a copy of the Code of Business Conduct and Ethics to any person without charge, upon request. Requests can be sent to: Independence Energy Corp., 3020 Old Ranch Parkway, Suite 300, Seal Beach, CA, 90740.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Securities Exchange Act of 1934 requires our directors, executive officers, and persons who beneficially own more than ten percent of a registered class of our equity securities to file with the SEC initial reports of ownership and reports of change in ownership of common stock and other equity securities of our company. Officers, directors and greater than ten percent stockholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file. Based solely upon a review of Forms 3 and 4 and amendments thereto furnished to us under Rule 16a-3(e) during the year ended January 31, 2014, Forms 5 and any amendments thereto furnished to us with respect to the year ended January 31, 2014, and the representations made by the reporting persons to us, we believe that during the year ended January 31, 2014, our executive officers and directors and all persons who own more than ten percent of a registered class of our equity securities complied with all Section 16(a) filing requirements.

Item 11. Executive Compensation

The particulars of the compensation paid to the following persons:

(a)

our principal executive officer;

(b)

each of our two most highly compensated executive officers who were serving as executive officers at the end of the years ended January 31, 2014 and 2013; and

(c)

up to two additional individuals for whom disclosure would have been provided under (b) but for the fact that the individual was not serving as our executive officer at the end of the years ended January 31, 2014 and 2013,

who we will collectively refer to as the named executive officers of our company, are set out in the following summary compensation table, except that no disclosure is provided for any named executive officer, other than our principal executive officers, whose total compensation did not exceed $100,000 for the respective fiscal year:

SUMMARY COMPENSATION TABLE

Name and

Principal Position

Year

Salary

($)

Bonus

($)

Stock

Awards

($)

Option

Awards

($)

Non-Equity

Incentive

Plan

Compensation

($)

Change in

Pension

Value and

Nonqualified

Deferred

Compensation

Earnings

($)

All Other

Compensation

($)

Total

($)

Gregory Rotelli(1)

2014

76,000

Nil

76,000

President, CFO, Treasurer,

2013

36,000

Nil

36,000

Secretary, and Director

1.	Mr. Gregory Rotelli has been a director of our company since November 30, 2011. He was appointed as chief executive officer, chief financial officer, treasurer, secretary of our company on February 22, 2012 and resigned as chief executive officer on March 31, 2014.

Narrative Disclosure to Summary Compensation Table

There are no compensatory plans or arrangements, including payments to be received from our company with respect to any executive officer, that would result in payments to such person because of his or her resignation, retirement or other termination of employment with our company, or its subsidiaries, any change in control, or a change in the person’s responsibilities following a change in control of our company.

Stock Option Plan

Currently, we do not have a stock option plan in favor of any director, officer, consultant or employee of our company.

Stock Options/SAR Grants

During our fiscal year ended January 31, 2014 there were no options granted to our named officers or directors.

Outstanding Equity Awards at Fiscal Year End

No equity awards were outstanding as of the year ended January 31, 2014.

Option Exercises

During our fiscal year ended January 31, 2014 there were no options exercised by our named officers.

Compensation of Directors

We do not have any agreements for compensating our directors for their services in their capacity as directors, other than as previously filed, although such directors are expected in the future to receive stock options to purchase shares of our common stock as awarded by our board of directors. We have not made any determination as to whether any of our newly appointed directors are independent directors, as that term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(15) of the NASDAQ Marketplace Rules. We have determined that Gregory Rotelli is not an independent director.

Pension, Retirement or Similar Benefit Plans

There are no arrangements or plans in which we provide pension, retirement or similar benefits for directors or executive officers. We have no material bonus or profit sharing plans pursuant to which cash or non-cash compensation is or may be paid to our directors or executive officers, except that stock options may be granted at the discretion of the board of directors or a committee thereof.

Indebtedness of Directors, Senior Officers, Executive Officers and Other Management

None of our directors or executive officers or any associate or affiliate of our company during the last two fiscal years, is or has been indebted to our company by way of guarantee, support agreement, letter of credit or other similar agreement or understanding currently outstanding.

Compensation Committee

We currently do not have a compensation committee of the board of directors. The board of directors as a whole determines executive compensation.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The following table sets forth certain information concerning the number of shares of our common stock owned beneficially as of April 28, 2014, by: (i) our directors; (ii) our named executive officer; and (iii) each person or group known by us to beneficially own more than 5% of our outstanding shares of common stock, as well as by each of our current directors and executive officers as a group. Unless otherwise indicated, the shareholders listed below possess sole voting and investment power with respect to the shares they own. Beneficial ownership consists of a direct interest in the shares of common stock, except as otherwise indicated.

Name and Address of Beneficial Owner	Title of Class	Amount and Nature of Beneficial Ownership			Percentage of Class(1)

Gregory Rotelli (2) 3020 Old Ranch Parkway, Suite 300 Seal Beach, CA 90740	Common		56,755,000			16.44	%

Howard J. Taylor (3) 3020 Old Ranch Parkway, Suite 300 Seal Beach, CA 90740	Common		19,021,536	(4)		5.51	%

Daniel J. Schreiber (5) 3020 Old Ranch Parkway, Suite 300 Seal Beach, CA 90740	Common		57,064,608	(6)		16.53	%

Directors and Officers as a group	Common		132,841,144			38.48	%

Beechwood Properties, LLC (7) Post Office Box 53929 Lafayette, Louisiana	Common		57,064,608			16.53	%

Paul A. Rachmuth 265 Sunrise Highway, Ste. 63 Rockville Centre, New York 11570	Common		19,021,536			5.51	%

Other over 5% holders	Common		76,086,144			22.04	%

(1)

Under Rule 13d-3, a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding, relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares; and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares).In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided .In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in this table does not necessarily reflect the person’s actual ownership or voting power with respect to the number of shares of common stock actually outstanding on April 28, 2014. As of April 28, 2014, there were 345,188,164 shares of our company’s common stock issued and outstanding.

(2)	Mr. Gregory Rotelli has been a director of our company since November 30, 2011. He was appointed as chief executive officer, chief financial officer, treasurer, secretary of our company on February 22, 2012 and resigned as chief executive officer on March 31, 2014.

(3)	Howard J. Taylor was appointed as chief executive officer, chairman and as a director of our company on March 31, 2014.

(4)	Includes 19,021,539 shares held by Concorde Capital Limited, a corporation over whose securities Mr. Taylor has voting and dispositive control.

(5)	Daniel J. Schreiber was appointed as a director of our company on March 31, 2014.

(6)	Includes 57,064,608 shares held by the Schreiber Living Trust-DTD 2/08/95 In Care of Avior Capital LLC. Mr. Schreiber has voting and dispositive control over securities held by Schreiber Living Trust and Avior Capital LLC

(7)	Darcy Klug has voting and dispositive control over securities held by Beechwood Properties, LLC.

Changes in Control

We are unaware of any contract or other arrangement or provisions of our Articles or Bylaws the operation of which may at a subsequent date result in a change of control of our company. There are not any provisions in our Articles or Bylaws, the operation of which would delay, defer, or prevent a change in control of our company.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Except as disclosed herein, no director, executive officer, shareholder holding at least 5% of shares of our common stock, or any family member thereof, had any material interest, direct or indirect, in any transaction, or proposed transaction since the year ended January 31, 2014, in which the amount involved in the transaction exceeded or exceeds the lesser of $120,000 or one percent of the average of our total assets at the year-end for the last three completed fiscal years.

Director Independence

We currently act with three directors, consisting of Gregory Rotelli, Howard J. Taylor and Daniel J. Schreiber. We have determined that Gregory Rotelli is not an “independent director” as defined in NASDAQ Marketplace Rule 4200(a)(15). We have not make any determination regarding the independence of Messrs Taylor and Schreiber. We do not have a standing audit, compensation or nominating committee, but ours director and officers acts in such capacities. We believe that our directors are capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. Our directors do not believe that it is necessary to have an audit committee because we believe that the functions of an audit committee can be adequately performed by the sole director. In addition, we believe that retaining an independent director who would qualify as an “audit committee financial expert” would be overly costly and burdensome and is not warranted in our circumstances given the early stages of our development.

Item 14. Principal Accountant Fees and Services

	Year Ended
	January 31, 2014		January 31, 2013

Audit Fees	$	17,000	$	12,000
Audit Related Fees	$	Nil	$	Nil
Tax Fees	$	Nil	$	Nil
All Other Fees	$	Nil	$	Nil
Total	$	17,000	$	12,000

Our board of directors pre-approves all services provided by our independent auditors. All of the above services and fees were reviewed and approved by the board of directors either before or after the respective services were rendered.

Our board of directors has considered the nature and amount of fees billed by our independent auditors and believes that the provision of services for activities unrelated to the audit is compatible with maintaining our independent auditors’ independence.

PART IV

Item 15. Exhibits, Financial Statement Schedules

(a) Financial Statements

(1)

Financial statements for our company are listed in the index under Item 8 of this document

(2)

All financial statement schedules are omitted because they are not applicable, not material or the required information is shown in the financial statements or notes thereto.

(b) Exhibits

Exhibit Number		Description of Exhibit

(3)		Articles of Incorporation and Bylaws

3.01		Articles of Incorporation (incorporated by reference to our Registration Statement on Form SB-2 filed on March 7, 2006)

3.02		Bylaws (incorporated by reference to our Registration Statement on Form SB-2 filed on March 7, 2006)

3.03		Certificate of Amendment filed on July 23, 2008 (incorporated by reference to our Current Report on Form 8-K filed on August 14, 2008)

3.04		Certificate of Change filed on July 23, 2008 (incorporated by reference to our Current Report on Form 8-K filed on August 14, 2008)

3.05		Certificate of Change filed on June 14, 2012 (incorporated by reference to our Current Report on Form 8-K filed on June 16, 2012)

(10)		Material Contracts

10.1		Share Purchase Agreement dated January 24, 2012 between Gregory Rotelli and Bruce Thomson (incorporated by reference to our Current Report on Form 8-K filed on January 30, 2012)

10.2		Form of Financing Agreement dated May 24, 2012 (incorporated by reference to our Current Report on Form 8-K filed on May 24, 2012)

10.3		Purchase Agreement and Bill of Sale dated May 29, 2012 between our company and MontCrest Energy, Inc. (incorporated by reference to our Current Report on Form 8-K filed on June 1, 2012)

10.4		Joint Development and Operating Agreement dated June 8, 2012 between our company and MontCrest Energy Properties, Inc., MontCrest Energy, Inc., and Black Strata, LLC (incorporated by reference to our Current Report on Form 8-K filed on June 12, 2012)

10.5		Purchaser Agreement and Bill of Sale dated June 18, 2012 between our company and MontCrest Energy, Inc. (incorporated by reference to our Current Report on Form 8-K filed on June 19, 2012)

10.6		Compromise, Settlement and Property Exchange Agreement dated February 25, 2013 between our company and MontCrest Energy, Inc. and Black Strata, LLC (incorporated by reference to our Current Report on Form 8-K filed on March 7, 2013)

10.7		Form of Convertible Debenture dated for reference April 5, 2012 issued to Europa Capital AG (incorporated by reference to our Current Report on Form 8-K filed on April 9, 2013)

10.8		Form of Securities Purchase Agreement dated September 17, 2013 between our company and Asher Enterprises, Inc. (incorporated by reference to our Current Report on Form 8-K filed on July 29, 2013)

10.9		Form of Convertible Promissory Note dated September 17, 2013 issued to Asher Enterprises Inc. (incorporated by reference to our Current Report on Form 8-K filed on July 29, 2013)

10.10		Consulting Agreement dated September 1, 2013 between our company and Gregory Rotelli (incorporated by reference to our Quarterly Report on Form 10-Q filed on September 16, 2013)

10.11		Asset Purchase Agreement dated March 31, 2014 between our company and with American Medical Distributors (incorporated by reference to our Current Report on Form 8-K filed on April 2, 2014)

10.12		Assignment Agreement dated March 18, 2014 between our company, American Medical Distributors, Inc. and HuBDIC Co. Ltd. (incorporated by reference to our Current Report on Form 8-K filed on April 2, 2014)

10.13		Distribution Agreement dated November 27, 2013 between HuBDIC Co. Ltd. and American Medical Distributors, Inc. (incorporated by reference to our Current Report on Form 8-K filed on April 2, 2014)

(14)		Code of Ethics

14.1		Code of Ethics (incorporated by reference to our Annual Report on Form 10-K filed on May 15, 2012)

(31)		Rule 13a-14(a) / 15d-14(a) Certifications

31.1*		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer

31.2*		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer

(32)		Section 1350 Certifications

32.1*		Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer

32.2*		Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer

101**		Interactive Data File (Form 10-K for the year ended January 31, 2014 furnished in XBRL).
101.INS 101.SCH 101.CAL 101.DEF 101.LAB 101.PRE		XBRL Instance Document XBRL Taxonomy Extension Schema Document XBRL Taxonomy Extension Calculation Linkbase Document XBRL Taxonomy Extension Definition Linkbase Document XBRL Taxonomy Extension Label Linkbase Document XBRL Taxonomy Extension Presentation Linkbase Document

*	Filed herewith.

**	To be provided by amendment.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, our company caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INDEPENDENCE ENERGY, CORP.
	(Registrant)


Dated: May 1, 2014	/s/ Howard J. Taylor
	Howard J. Taylor
	Chief Executive Officer and Director
	(Principal Executive Officer)


Dated: May 1, 2014	/s/ Gregory Rotelli
	Gregory Rotelli
	President, Chief Financial Officer, Treasurer, Secretary and Director
	(Principal Financial Officer and Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



Dated: May 1, 2014	/s/ Howard J. Taylor
	Howard J. Taylor
	Chief Executive Officer and Director
	(Principal Executive Officer)


Dated: May 1, 2014	/s/ Gregory Rotelli
	Gregory Rotelli
	President, Chief Financial Officer, Treasurer, Secretary and Director
	(Principal Financial Officer and Principal Accounting Officer)

Attached files

Stock widget

Investing forum

RedHawk Holdings Corp. Reports

Also read